PLAU and diabetic kidney disease: Thus, these findings point to Lipocalin-2/NGAL as a key biomarker in LN, whereas EGF showed significant positive correlations with ASC, IL-18, uPA, and NGAL, suggesting that EGF is a key biomarker in DKD.